Clinics and Research in Hepatology and Gastroenterology
Mini reviewPathophysiology and current management of pruritus in liver disease
Section snippets
Definition and prevalence
The observation that pruritus accompanies jaundice has already been made by the ancient Greek physician Aretæus the Cappadocian in the 2nd century BC [1]. Today, itch is well known as a frequent and agonizing symptom accompanying many types of liver diseases, particularly those with cholestatic features [2], [3], [4]. In these disorders, cholestasis may be due to:
- •
impaired hepatocellular secretion as observed in intrahepatic cholestasis of pregnancy (ICP), benign recurrent intrahepatic
Clinical picture
Although pruritus is frequently undervalued by clinicians, it is often the major burden of the cholestatic patient and can dramatically reduce quality of life. Pruritus may be mild and tolerable, but does, in some patients, limit activities of daily life and cause severe sleep deprivation resulting in lassitude, fatigue, depression and even suicidal sensation. In rare cases, intractable pruritus may become a primary indication for liver transplantation even in the absence of liver failure [4],
Bile salts
Aretæus, the Cappadocian, explained the itchy skin in jaundiced patients by prickly bilious particles [1]. More than two millennia later, his hypothesis is at least partly still valid as the removal of bile from the body either by external biliary diversion [21], [22], [23] or nasobiliary drainage [24], [25], [26] quickly and dramatically alleviates severe cholestatic pruritus. Thus, certain biliary substances contribute either directly or indirectly to the onset of itching. During cholestasis,
Management
Treatment options for pruritus in cholestasis remain limited to a few evidence-based and several experimental medical and interventional therapies. Therapeutic interventions should primarily focus on an adequate therapy of the underlying hepatobiliary disease, as this may result in relief of pruritus.
The rationale for medical and interventional therapeutic approaches is:
- •
to remove the pruritogens from the enterohepatic cycle by non-absorbable, anion exchange resins such as cholestyramine,
Conflict of interest statement
The authors have no conflicts of interest that are directly relevant to the content of this review.
Funding: Supported by the Deutsche Forschungsgemeinschaft (KR3618/1-1 to A.E.K.).
References (139)
- et al.
Pruritus and fatigue in primary biliary cirrhosis
Baillieres Best Pract Res Clin Gastroenterol
(2000) - et al.
Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome
Hepatology
(2002) - et al.
Nasobiliary drainage in acute cholestatic hepatitis with pruritus
Dig Liver Dis
(2009) Bile acids in the serum of jaundiced patients
Gastroenterology
(1961)- et al.
Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis
Gastroenterology
(1966) - et al.
Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus
J Pediatr Surg
(1998) - et al.
Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus
Gastroenterology
(1977) - et al.
Pruritus in cholestasis: no direct causative role for bile acid retention
Am J Med
(1981) - et al.
Efficacy and safety of long-term phenobarbital therapy of familial cholestasis
J Pediatr
(1978) - et al.
Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial
Gastroenterology
(1988)